Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignances

Christopher W. Ryan, Nicholas J. Vogelzang, Everett E. Vokes, Hedy L. Kindler, Samir D. Undevia, Rod Humerickhouse, Amy K. André, Qiang Wang, Robert A. Carr, Mark J. Ratain

    Research output: Contribution to journalArticlepeer-review

    40 Scopus citations

    Fingerprint Dive into the research topics of 'Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignances'. Together they form a unique fingerprint.

    Medicine & Life Sciences